Literature DB >> 18505445

Effect of anaesthetic agents on p-wave dispersion on the electrocardiogram: comparison of propofol and desflurane.

Radoslaw Owczuk1, Magdalena A Wujtewicz, Wioletta Sawicka, Agnieszka Polak-Krzeminska, Aleksandra Suszynska-Mosiewicz, Krystyna Raczynska, Maria Wujtewicz.   

Abstract

Anaesthetics influence cardiac electrical activity by various mechanisms; thus, they may have pro-arrhythmic or anti-arrhythmic actions. Increased P-wave dispersion is associated with a risk of paroxysmal atrial fibrillation. The aim of the present study was to analyse the impact of propofol and desflurane on changes in P wave dispersion, which may reflect the anti-arrhythmic effects of these drugs. Fifty patients undergoing scheduled surgery were included in the study. Patients were divided into two equal groups: a propofol group and a desflurane group. Patients in the propofol group were initially administered 2.5 mg/kg propofol, followed by infusion of 6 mg/kg per h propofol. Anaesthesia in the desflurane group was achieved using inhalation induction, with concentrations up to 8-12.5 vol%. When signs of adequate anaesthesia were observed, the concentration of desflurane was reduced to 6 vol%. An electrocardiogram (ECG) was obtained before induction and then again 1, 3 and 5 min after the initiation of propofol infusion or the induction of anaesthesia in the desflurane group; additional measurements were performed after tracheal intubation. P-wave dispersion was assessed by differences in maximal and minimal P-wave duration on a 12-lead ECG. P-wave dispersion did not change over time in the desflurane group. In the propofol group, there was a significant decrease in P-wave dispersion after 3 and 5 min of anaesthesia. Significant differences were observed between study groups after 1, 3 and 5 min of anaesthesia, and disappeared after tracheal intubation. Mean and maximal P-wave duration did not change in either group. In conclusion, propofol decreases P-wave dispersion and this seems to be connected with the anti-arrhythmic properties of the drug.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505445     DOI: 10.1111/j.1440-1681.2008.04963.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

1.  Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements.

Authors:  James E Tisdale; Matthew R Allen; Brian R Overholser; Heather A Jaynes; Richard J Kovacs
Journal:  J Cardiovasc Electrophysiol       Date:  2015-03-31

Review 2.  Propofol and arrhythmias: two sides of the coin.

Authors:  Qiang Liu; Ai-ling Kong; Rong Chen; Cheng Qian; Shao-wen Liu; Bao-gui Sun; Le-xin Wang; Long-sheng Song; Jiang Hong
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

3.  Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine.

Authors:  Carsten Stoetzer; Svenja Reuter; Thorben Doll; Nilufar Foadi; Florian Wegner; Andreas Leffler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-15       Impact factor: 3.000

4.  Effects of balanced propofol sedation on QT, corrected QT, and P-wave dispersion on upper endoscopy.

Authors:  Esef Bolat; Mehmet Çelikbilek; Savaş Sarıkaya; Yunus Keser Yılmaz; Serkan Doğan; Ömer Özbakır
Journal:  Anatol J Cardiol       Date:  2015-07-03       Impact factor: 1.596

5.  An Easy and Reliable Way to Prevent Electrocardiographic Deteriorations of Patients Undergoing Off-Pump Coronary Artery Bypass Surgery: Preoperative Anxiolytic Treatment.

Authors:  Abdullah Demirhan; Yusuf Velioglu; Hamit Yoldas; Ibrahim Karagoz; Mehmet Cosgun; Duygu Caliskan; Isa Yildiz; Murat Bilgi; Kemalettin Erdem
Journal:  Braz J Cardiovasc Surg       Date:  2019-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.